Segura J - Search Results

1

Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain.

Gorostidi M, Sarafidis PA, de la Sierra A, Segura J, de la Cruz JJ, Banegas JR, Ruilope LM; Spanish ABPM Registry Investigators. Gorostidi M, et al. Among authors: segura j. Am J Kidney Dis. 2013 Aug;62(2):285-94. doi: 10.1053/j.ajkd.2013.03.025. Epub 2013 May 18. Am J Kidney Dis. 2013. PMID: 23689071

2

Comparative study of home and office blood pressure in hypertensive patients treated with enalapril/HCTZ 20/6 mg: the ESPADA study.

Campo C, Fernández G, González-Esteban J, Segura J, Ruilope LM; ESPADA Study Group. Campo C, et al. Among authors: segura j. Blood Press. 2000;9(6):355-62. doi: 10.1080/080370500300000941. Blood Press. 2000. PMID: 11212065

3

A prospective comparison of four antihypertensive agents in daily clinical practice.

Campo C, Segura J, Fernández ML, Guerrero L, Christiansen H, Ruilope LM. Campo C, et al. Among authors: segura j. J Clin Hypertens (Greenwich). 2001 May-Jun;3(3):139-44. doi: 10.1111/j.1524-6175.2001.00448.x. J Clin Hypertens (Greenwich). 2001. PMID: 11430394 Free PMC article. Clinical Trial.

4

[Relationship between severity of essential arterial hypertension and the prevalence hyperuricemia].

Campo C, García Puig J, Segura J, María Alcázar J, García-Robles R, Ruilope LM. Campo C, et al. Among authors: segura j. Med Clin (Barc). 2001 Jun 23;117(3):85-9. doi: 10.1016/s0025-7753(01)72025-8. Med Clin (Barc). 2001. PMID: 11459575 Spanish.

5

The calcium channel blocker controversy in patients with diabetic nephropathy: Is there an issue?

Ruilope LM, Campo C, Segura J. Ruilope LM, et al. Among authors: segura j. Curr Hypertens Rep. 2001 Oct;3(5):419-21. doi: 10.1007/s11906-001-0060-4. Curr Hypertens Rep. 2001. PMID: 11551377 Review.

6

ACE inhibitors and appearance of renal events in hypertensive nephrosclerosis.

Segura J, Campo C, Rodicio JL, Ruilope LM. Segura J, et al. Hypertension. 2001 Sep;38(3 Pt 2):645-9. doi: 10.1161/hy09t1.096184. Hypertension. 2001. PMID: 11566948

7

A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease.

Marin R, Ruilope LM, Aljama P, Aranda P, Segura J, Diez J; Investigators of the ESPIRAL Study. Efecto del tratamiento antihipertensivo Sobre la Progresión de la Insuficiencia RenAL en pacientes no diabéticos. Marin R, et al. Among authors: segura j. J Hypertens. 2001 Oct;19(10):1871-6. doi: 10.1097/00004872-200110000-00023. J Hypertens. 2001. PMID: 11593109 Clinical Trial.

8

What is the optimal blood pressure target in renal patients?

Ruilope LM, Campo C, Segura J, Rodicio JL. Ruilope LM, et al. Among authors: segura j. Adv Nephrol Necker Hosp. 2001;31:43-53. Adv Nephrol Necker Hosp. 2001. PMID: 11692470 Review.

9

Factors influencing the systolic blood pressure response to drug therapy.

Campo C, Segura J, Ruilope LM. Campo C, et al. Among authors: segura j. J Clin Hypertens (Greenwich). 2002 Jan-Feb;4(1):35-40. doi: 10.1111/j.1524-6175.2002.00487.x. J Clin Hypertens (Greenwich). 2002. PMID: 11821635 Free PMC article. Review.

10

Renal protection by antihypertensive therapy.

Ruilope LM, Segura J. Ruilope LM, et al. Among authors: segura j. Curr Hypertens Rep. 2002 Aug;4(4):324-8. doi: 10.1007/s11906-996-0012-0. Curr Hypertens Rep. 2002. PMID: 12117461 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,247 results

Search Page